XETRA - Delayed Quote EUR
Newron Pharmaceuticals S.p.A. (NP5.DE)
7.51
-0.12
(-1.57%)
At close: April 25 at 5:35:38 PM GMT+2
Breakdown
TTM
12/31/2023
12/31/2022
12/31/2021
12/31/2020
Operating Cash Flow
-10,140
-10,140
-11,092
-11,445
-15,588
Investing Cash Flow
3,246
3,246
-317
8,420
-616
Financing Cash Flow
-192
-192
-186
14,831
7,365
End Cash Position
6,338
6,338
13,424
25,019
13,213
Capital Expenditure
-11
-11
-18
-20
-35
Issuance of Debt
--
--
--
15,000
7,500
Free Cash Flow
-10,151
-10,151
-11,110
-11,465
-15,623
12/31/2020 - 7/4/2019
Upgrade to begin using 40 years of financial statements and get so much more.
Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.
UpgradeRelated Tickers
AYJ.DE Valneva SE
3.1560
+0.32%
88Q.DE 4basebio PLC
12.90
0.00%
NVV1.DE Novavax, Inc.
7.85
-0.53%
7V0.DE Darwin AG
27.40
0.00%
BIO.DE Biotest Aktiengesellschaft
42.40
0.00%
9VC.DE Atai Life Sciences N.V.
1.3155
-2.01%
VX1.DE Vertex Pharmaceuticals Incorporated
430.90
-0.29%
BIO3.DE Biotest Aktiengesellschaft
30.20
0.00%
HPHA.DE Heidelberg Pharma AG
2.8200
+1.08%
FYB.DE Formycon AG
23.05
+1.32%